Filing Details
- Accession Number:
- 0001209191-19-007776
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-06 16:51:35
- Reporting Period:
- 2019-02-04
- Accepted Time:
- 2019-02-06 16:51:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406338 | Amit Sachdev | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cro | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-04 | 1,942 | $86.52 | 48,604 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-04 | 1,200 | $186.57 | 47,404 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-04 | 742 | $187.35 | 46,662 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-02-04 | 2,155 | $91.05 | 48,817 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-04 | 1,120 | $186.52 | 47,697 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-04 | 1,035 | $187.23 | 46,662 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-04 | 5,000 | $186.55 | 41,662 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-04 | 3,625 | $187.30 | 38,037 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-04 | 1,942 | $86.52 | 1,942 | $86.52 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-04 | 2,155 | $91.05 | 2,155 | $91.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,533 | 2027-02-02 | No | 4 | M | Direct | |
| 8,622 | 2026-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,215 | Indirect | Held in Trust |
| Common Stock | 882 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $186.57 (range $185.99 to $186.90).
- Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $187.35 (range $187.03 to $187.59).
- Open market sales reported on this line occurred at a weighted average price of $186.52 (range $185.90 to $186.89).
- Open market sales reported on this line occurred at a weighted average price of $187.23 (range $186.94 to $187.60).
- Open market sales reported on this line occurred at a weighted average price of $186.55 (range $185.90 to $186.90).
- Open market sales reported on this line occurred at a weighted average price of $187.30 (range $186.92 to $187.63).
- The option vests in 16 quarterly installments from 2/3/2017.
- The option vests in 16 quarterly installments from 2/2/2016.
Billionaire Hedge Funds
